H

HighCape Partners

10 employees

A growth equity firm that invests in companies that are commercializing high-margin life sciences products.

Investor insights

Sectors invested in

Health Care7
Biotechnology6
Medical Device5
Therapeutics4
DDR3
oncology3
PARP inhibitor3
Phase I3
drug development3
biotech3
Pharmaceutical3
Consumer Products2
Pulmonology2
Medical2
Fitness2
Marketing2
Asthma2
COPD2
Healthcare2
Nebulizer2

Funding rounds participated in

$12M sweet spot round size

Most of their 11 investments are in rounds between $6.4M and $14M

Investor type

Micro VC

Basic info

Industry

other

Sectors

Financial Services

Date founded

2013

Investments made

M

Modifi Bio raised $6.4M on July 28, 2022

Investors: National Brain Tumor Society, Ironwood Capital, Yale Office of Cooperative Research and HighCape Partners

W

Wellinks raised $25M on November 3, 2021

Investors: Stonehenge Capital and HighCape Partners

C

Cybrexa Therapeutics raised $25M on March 10, 2021

Investors: Elm Street Ventures, Advantage Capital and HighCape Partners

A

Alphina Therapeutics raised undisclosed on December 15, 2020

Investors: HighCape Partners

f

flypnebulizer raised $4M on September 27, 2019

Investors: Stonehenge Capital and HighCape Partners

W

Wellinks raised $14M on September 26, 2019

Investors: Stonehenge Capital and HighCape Partners

C

Cybrexa Therapeutics raised $13M on June 21, 2019

Investors: HighCape Partners

Z

Zipline Medical raised $9M on June 19, 2018

Investors: Bridge Bank, MVM Partners and HighCape Partners

C

Cybrexa Therapeutics raised $6M on June 16, 2017

Investors: HighCape Partners

A

Aziyo Biologics, Inc. raised $12M on June 14, 2017

Investors: MidCap Financial and HighCape Partners

FAQ